Redox activation of metal-based prodrugs as a strategy for drug delivery
This review provides an overview of metal-based anticancer drugs and drug candidates. In particular, we focus on metal complexes that can be activated in the reducing environment of cancer cells, thus serving as prodrugs. There are many reports of Pt and Ru complexes as redox-activatable drug candid...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | en_US |
| Published: |
2016
|
| Online Access: | http://hdl.handle.net/1721.1/103939 https://orcid.org/0000-0002-2693-4982 |